Immune Checkpoint Inhibitor Associated Cardiovascular Adverse Events in Patients With Cancer

Clinical trial NCT06519292 · RECRUITING

Trial details

NCT number: NCT06519292
Sponsor: Hanneke W. M. van Laarhoven
Status: RECRUITING
Study type: OBSERVATIONAL

Cardiovascular Diseases Arterial Thrombosis Myocardial Infarction Stroke Coronary Artery Disease Atherosclerosis Cancer

Start date: 2023-01-25
Primary completion: 2025-12-31
Enrollment: 214

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.